Gene Symbol | Gene ID | Gene Info |
---|---|---|
EBF3
|
ENSG00000108001.9 | EBF transcription factor 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_131751118_131751269 | EBF3 | 10912 | 0.299280 | 0.97 | 1.5e-05 | Click! |
chr10_131749932_131750083 | EBF3 | 12098 | 0.295449 | 0.95 | 1.2e-04 | Click! |
chr10_131749490_131749641 | EBF3 | 12540 | 0.294073 | 0.94 | 1.5e-04 | Click! |
chr10_131751337_131751488 | EBF3 | 10693 | 0.300019 | 0.91 | 6.7e-04 | Click! |
chr10_131749173_131749324 | EBF3 | 12857 | 0.293097 | 0.87 | 2.1e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_50433408_50433958 | 2.08 |
ATF5 |
activating transcription factor 5 |
207 |
0.7 |
chr9_140162312_140162640 | 2.01 |
TOR4A |
torsin family 4, member A |
9725 |
0.07 |
chr7_5492937_5493176 | 1.72 |
TNRC18 |
trinucleotide repeat containing 18 |
28011 |
0.1 |
chr10_133999367_134000256 | 1.70 |
RP11-140A10.3 |
|
345 |
0.67 |
chr11_73024899_73025487 | 1.56 |
ARHGEF17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
2583 |
0.2 |
chr9_91144416_91144843 | 1.49 |
NXNL2 |
nucleoredoxin-like 2 |
5387 |
0.32 |
chr14_100479429_100479580 | 1.48 |
EVL |
Enah/Vasp-like |
6215 |
0.21 |
chr2_42795325_42795726 | 1.44 |
MTA3 |
metastasis associated 1 family, member 3 |
132 |
0.97 |
chr11_73028491_73028768 | 1.43 |
ARHGEF17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
6019 |
0.15 |
chr11_8739855_8740017 | 1.41 |
ST5 |
suppression of tumorigenicity 5 |
88 |
0.95 |
chr1_27425346_27425645 | 1.39 |
SLC9A1 |
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
55478 |
0.1 |
chr9_96720941_96721916 | 1.39 |
BARX1 |
BARX homeobox 1 |
3774 |
0.31 |
chr2_121370803_121371147 | 1.38 |
ENSG00000201006 |
. |
37874 |
0.21 |
chr1_26629293_26629444 | 1.38 |
UBXN11 |
UBX domain protein 11 |
139 |
0.93 |
chr6_156342055_156342206 | 1.37 |
ENSG00000221456 |
. |
74199 |
0.13 |
chr4_38083739_38084038 | 1.37 |
TBC1D1 |
TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 |
36396 |
0.22 |
chr17_76330977_76331356 | 1.35 |
SOCS3 |
suppressor of cytokine signaling 3 |
24989 |
0.13 |
chr7_151362310_151362461 | 1.34 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
32134 |
0.19 |
chr16_67282984_67283686 | 1.34 |
SLC9A5 |
solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 |
482 |
0.57 |
chr22_46402793_46403252 | 1.34 |
WNT7B |
wingless-type MMTV integration site family, member 7B |
30013 |
0.1 |
chr16_15905428_15905645 | 1.33 |
MYH11 |
myosin, heavy chain 11, smooth muscle |
45332 |
0.11 |
chr19_15559479_15560330 | 1.32 |
ENSG00000269782 |
. |
455 |
0.47 |
chr1_208064132_208064479 | 1.31 |
CD34 |
CD34 molecule |
468 |
0.88 |
chr5_71453276_71453427 | 1.30 |
ENSG00000264099 |
. |
11943 |
0.23 |
chr11_61772970_61773448 | 1.30 |
AP003733.1 |
Uncharacterized protein; cDNA FLJ36460 fis, clone THYMU2014801 |
37756 |
0.11 |
chr17_41613704_41613971 | 1.26 |
ETV4 |
ets variant 4 |
6035 |
0.15 |
chr3_8570408_8570559 | 1.26 |
LMCD1 |
LIM and cysteine-rich domains 1 |
8386 |
0.22 |
chr15_68682519_68683065 | 1.25 |
ITGA11 |
integrin, alpha 11 |
41700 |
0.18 |
chr14_69015594_69016105 | 1.24 |
CTD-2325P2.4 |
|
79313 |
0.1 |
chr15_81475008_81475363 | 1.24 |
IL16 |
interleukin 16 |
15 |
0.98 |
chr18_457195_458136 | 1.20 |
RP11-720L2.2 |
|
33249 |
0.16 |
chr16_90074368_90074645 | 1.20 |
DBNDD1 |
dysbindin (dystrobrevin binding protein 1) domain containing 1 |
2023 |
0.2 |
chr1_41962099_41962530 | 1.20 |
EDN2 |
endothelin 2 |
11972 |
0.2 |
chr22_46505540_46505836 | 1.17 |
ENSG00000198986 |
. |
2941 |
0.13 |
chr12_132269539_132269690 | 1.16 |
ENSG00000200516 |
. |
16365 |
0.16 |
chr17_55944951_55945540 | 1.16 |
CUEDC1 |
CUE domain containing 1 |
469 |
0.8 |
chr10_21687831_21687982 | 1.15 |
ENSG00000207264 |
. |
77016 |
0.08 |
chr5_378642_378793 | 1.14 |
AHRR |
aryl-hydrocarbon receptor repressor |
35074 |
0.13 |
chr19_42617979_42618462 | 1.13 |
POU2F2 |
POU class 2 homeobox 2 |
2819 |
0.14 |
chr17_66572562_66572713 | 1.13 |
FAM20A |
family with sequence similarity 20, member A |
24893 |
0.18 |
chr17_70461708_70461859 | 1.13 |
ENSG00000200783 |
. |
198508 |
0.03 |
chr10_105375918_105376069 | 1.12 |
RP11-416N2.4 |
|
7617 |
0.17 |
chr19_47524229_47524951 | 1.12 |
NPAS1 |
neuronal PAS domain protein 1 |
447 |
0.8 |
chr11_47628458_47628609 | 1.11 |
ENSG00000223187 |
. |
8013 |
0.09 |
chr6_44026555_44026902 | 1.11 |
RP5-1120P11.1 |
|
15661 |
0.16 |
chr7_90709812_90709963 | 1.11 |
FZD1 |
frizzled family receptor 1 |
183896 |
0.03 |
chr18_46260220_46260632 | 1.11 |
RP11-426J5.2 |
|
45636 |
0.16 |
chr3_119355805_119356256 | 1.11 |
POPDC2 |
popeye domain containing 2 |
23407 |
0.13 |
chr15_68911722_68911873 | 1.10 |
CORO2B |
coronin, actin binding protein, 2B |
2918 |
0.38 |
chr1_109938801_109939938 | 1.10 |
SORT1 |
sortilin 1 |
1204 |
0.42 |
chr3_123600718_123600990 | 1.10 |
MYLK |
myosin light chain kinase |
2295 |
0.36 |
chr9_91348798_91348949 | 1.09 |
ENSG00000265873 |
. |
11947 |
0.3 |
chr2_43273247_43273788 | 1.09 |
ENSG00000207087 |
. |
45115 |
0.19 |
chr17_38500621_38501691 | 1.09 |
RARA |
retinoic acid receptor, alpha |
337 |
0.77 |
chr5_9046438_9046817 | 1.09 |
ENSG00000266415 |
. |
7380 |
0.28 |
chr2_129063259_129063630 | 1.08 |
HS6ST1 |
heparan sulfate 6-O-sulfotransferase 1 |
12707 |
0.24 |
chr15_90754517_90755171 | 1.08 |
SEMA4B |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
10076 |
0.12 |
chr9_96922029_96922351 | 1.07 |
ENSG00000199165 |
. |
16044 |
0.15 |
chr1_156634093_156634737 | 1.07 |
RP11-284F21.7 |
|
3199 |
0.12 |
chr16_4378324_4378965 | 1.07 |
GLIS2 |
GLIS family zinc finger 2 |
3581 |
0.16 |
chr11_72896529_72896905 | 1.06 |
RP11-800A3.2 |
|
30241 |
0.13 |
chr11_67779955_67780302 | 1.06 |
ALDH3B1 |
aldehyde dehydrogenase 3 family, member B1 |
2338 |
0.17 |
chr20_42296054_42296851 | 1.06 |
MYBL2 |
v-myb avian myeloblastosis viral oncogene homolog-like 2 |
655 |
0.74 |
chr17_42985063_42985350 | 1.05 |
GFAP |
glial fibrillary acidic protein |
2798 |
0.13 |
chr10_80912775_80912926 | 1.05 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
84058 |
0.09 |
chr9_116364960_116365111 | 1.05 |
RGS3 |
regulator of G-protein signaling 3 |
9269 |
0.22 |
chr21_43468590_43468841 | 1.05 |
UMODL1 |
uromodulin-like 1 |
14353 |
0.18 |
chr11_124790886_124791503 | 1.04 |
HEPN1 |
hepatocellular carcinoma, down-regulated 1 |
2048 |
0.2 |
chr2_121695887_121696038 | 1.04 |
ENSG00000221321 |
. |
96687 |
0.08 |
chr2_137913926_137914077 | 1.04 |
THSD7B |
thrombospondin, type I, domain containing 7B |
99727 |
0.09 |
chr17_36620428_36620685 | 1.03 |
ARHGAP23 |
Rho GTPase activating protein 23 |
6912 |
0.17 |
chr16_58056428_58056721 | 1.03 |
MMP15 |
matrix metallopeptidase 15 (membrane-inserted) |
2896 |
0.18 |
chr17_40672913_40673143 | 1.02 |
ENSG00000265611 |
. |
6822 |
0.08 |
chr4_20534130_20534281 | 1.02 |
ENSG00000207732 |
. |
4307 |
0.27 |
chr16_89631756_89632659 | 1.02 |
RPL13 |
ribosomal protein L13 |
3429 |
0.13 |
chr5_60921647_60922495 | 1.01 |
C5orf64 |
chromosome 5 open reading frame 64 |
11565 |
0.22 |
chr1_22236518_22236840 | 1.01 |
HSPG2 |
heparan sulfate proteoglycan 2 |
13876 |
0.16 |
chr8_7773619_7773775 | 1.01 |
ZNF705B |
zinc finger protein 705B |
10162 |
0.14 |
chr6_11609482_11609633 | 1.01 |
TMEM170B |
transmembrane protein 170B |
71046 |
0.11 |
chr3_134082413_134082992 | 1.01 |
AMOTL2 |
angiomotin like 2 |
8052 |
0.23 |
chr1_226001199_226001845 | 1.01 |
EPHX1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
3686 |
0.18 |
chr5_139043863_139044152 | 1.01 |
CXXC5 |
CXXC finger protein 5 |
4867 |
0.24 |
chr9_110399429_110399916 | 1.01 |
ENSG00000202308 |
. |
25855 |
0.23 |
chr11_11994844_11994995 | 1.01 |
DKK3 |
dickkopf WNT signaling pathway inhibitor 3 |
35211 |
0.21 |
chr12_53321112_53321263 | 1.01 |
KRT8 |
keratin 8 |
934 |
0.47 |
chr2_3474011_3474213 | 1.00 |
TRAPPC12 |
trafficking protein particle complex 12 |
4668 |
0.18 |
chr11_32334737_32335009 | 1.00 |
WT1 |
Wilms tumor 1 |
87288 |
0.09 |
chr3_185450101_185450459 | 0.99 |
C3orf65 |
chromosome 3 open reading frame 65 |
19200 |
0.2 |
chr16_23434677_23434850 | 0.99 |
ENSG00000252838 |
. |
9566 |
0.15 |
chr19_5091166_5091506 | 0.99 |
KDM4B |
lysine (K)-specific demethylase 4B |
8873 |
0.24 |
chr4_77659920_77660071 | 0.99 |
RP11-359D14.2 |
|
19632 |
0.21 |
chr16_31009222_31009520 | 0.99 |
STX1B |
syntaxin 1B |
2905 |
0.12 |
chr5_150024242_150024393 | 0.99 |
SYNPO |
synaptopodin |
4077 |
0.17 |
chr16_24989692_24989896 | 0.99 |
ARHGAP17 |
Rho GTPase activating protein 17 |
36858 |
0.19 |
chr9_38026937_38027088 | 0.98 |
SHB |
Src homology 2 domain containing adaptor protein B |
42196 |
0.17 |
chr17_38084892_38085098 | 0.98 |
ORMDL3 |
ORM1-like 3 (S. cerevisiae) |
1141 |
0.36 |
chr17_45353575_45353931 | 0.98 |
ENSG00000238419 |
. |
16967 |
0.13 |
chr20_1303722_1304114 | 0.98 |
SDCBP2-AS1 |
SDCBP2 antisense RNA 1 |
2131 |
0.21 |
chr7_155049886_155050037 | 0.98 |
INSIG1 |
insulin induced gene 1 |
39525 |
0.15 |
chr12_2279763_2279914 | 0.98 |
CACNA1C-AS4 |
CACNA1C antisense RNA 4 |
52807 |
0.14 |
chr5_159306421_159306671 | 0.97 |
ADRA1B |
adrenoceptor alpha 1B |
37244 |
0.2 |
chr20_48565890_48566041 | 0.97 |
ENSG00000239157 |
. |
9028 |
0.13 |
chr3_123485177_123485471 | 0.97 |
MYLK |
myosin light chain kinase |
27364 |
0.17 |
chr9_13387407_13387558 | 0.97 |
MPDZ |
multiple PDZ domain protein |
107893 |
0.07 |
chr11_117092087_117092238 | 0.97 |
PCSK7 |
proprotein convertase subtilisin/kexin type 7 |
2722 |
0.19 |
chr1_244327653_244327804 | 0.96 |
ENSG00000244066 |
. |
60494 |
0.13 |
chr3_49842732_49843503 | 0.96 |
ENSG00000263506 |
. |
561 |
0.55 |
chr20_4906415_4906566 | 0.96 |
SLC23A2 |
solute carrier family 23 (ascorbic acid transporter), member 2 |
26197 |
0.16 |
chr5_148442349_148442592 | 0.96 |
SH3TC2 |
SH3 domain and tetratricopeptide repeats 2 |
155 |
0.81 |
chr19_38526637_38527071 | 0.96 |
ENSG00000221258 |
. |
17751 |
0.17 |
chr16_48570365_48570782 | 0.96 |
RP11-44I10.3 |
|
22999 |
0.17 |
chr15_50148578_50148980 | 0.96 |
ATP8B4 |
ATPase, class I, type 8B, member 4 |
20113 |
0.21 |
chr3_115430096_115430247 | 0.96 |
RP11-326J18.1 |
|
52791 |
0.16 |
chr2_101383320_101383471 | 0.95 |
NPAS2 |
neuronal PAS domain protein 2 |
53219 |
0.13 |
chr20_11436062_11436219 | 0.95 |
ENSG00000222281 |
. |
363599 |
0.01 |
chr2_18300363_18300514 | 0.95 |
ENSG00000212455 |
. |
78439 |
0.12 |
chr19_3374839_3375060 | 0.95 |
NFIC |
nuclear factor I/C (CCAAT-binding transcription factor) |
8365 |
0.19 |
chr3_52039773_52040512 | 0.94 |
RPL29 |
ribosomal protein L29 |
10184 |
0.09 |
chr2_43496469_43496754 | 0.94 |
AC010883.5 |
|
39899 |
0.17 |
chr15_63011813_63011964 | 0.94 |
TLN2 |
talin 2 |
7401 |
0.21 |
chr17_38227673_38228382 | 0.94 |
THRA |
thyroid hormone receptor, alpha |
317 |
0.83 |
chr2_65084933_65085167 | 0.94 |
ENSG00000199964 |
. |
23759 |
0.15 |
chr12_78587424_78587575 | 0.94 |
NAV3 |
neuron navigator 3 |
5357 |
0.34 |
chr3_99565765_99565916 | 0.94 |
FILIP1L |
filamin A interacting protein 1-like |
1616 |
0.46 |
chr1_23080051_23080202 | 0.94 |
ENSG00000216157 |
. |
4722 |
0.19 |
chr4_8475289_8475440 | 0.93 |
RP11-689P11.3 |
|
18695 |
0.17 |
chr16_85220395_85220808 | 0.93 |
CTC-786C10.1 |
|
15719 |
0.23 |
chr11_118504426_118504665 | 0.93 |
AP002954.3 |
|
2793 |
0.17 |
chr2_129058831_129058982 | 0.93 |
HS6ST1 |
heparan sulfate 6-O-sulfotransferase 1 |
17245 |
0.23 |
chr1_180143413_180143564 | 0.93 |
QSOX1 |
quiescin Q6 sulfhydryl oxidase 1 |
19456 |
0.21 |
chr5_72714092_72714243 | 0.93 |
FOXD1 |
forkhead box D1 |
30185 |
0.18 |
chr3_123431340_123431491 | 0.93 |
RP11-9N20.3 |
|
3283 |
0.24 |
chr14_74223966_74225150 | 0.93 |
ENSG00000264741 |
. |
892 |
0.43 |
chr9_91433712_91433863 | 0.92 |
ENSG00000265873 |
. |
72967 |
0.12 |
chr22_31004709_31005158 | 0.92 |
TCN2 |
transcobalamin II |
1742 |
0.21 |
chr14_59349493_59349644 | 0.92 |
ENSG00000221427 |
. |
111604 |
0.07 |
chr5_14264025_14264216 | 0.92 |
TRIO |
trio Rho guanine nucleotide exchange factor |
26966 |
0.27 |
chr9_130284478_130284823 | 0.92 |
FAM129B |
family with sequence similarity 129, member B |
46717 |
0.09 |
chr15_48704804_48704955 | 0.92 |
DUT |
deoxyuridine triphosphatase |
80276 |
0.09 |
chr7_157071749_157072064 | 0.91 |
ENSG00000266453 |
. |
26581 |
0.21 |
chr2_218768515_218768918 | 0.91 |
TNS1 |
tensin 1 |
180 |
0.96 |
chr1_85064390_85064541 | 0.91 |
CTBS |
chitobiase, di-N-acetyl- |
24318 |
0.17 |
chr1_226005147_226005298 | 0.90 |
EPHX1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
7386 |
0.15 |
chr19_6273043_6273704 | 0.90 |
MLLT1 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1 |
6586 |
0.15 |
chr6_3701269_3701420 | 0.90 |
PXDC1 |
PX domain containing 1 |
37784 |
0.17 |
chr21_44056372_44056523 | 0.90 |
AP001626.2 |
|
14907 |
0.17 |
chr11_65343918_65345038 | 0.90 |
EHBP1L1 |
EH domain binding protein 1-like 1 |
961 |
0.3 |
chr13_46616123_46616274 | 0.90 |
ZC3H13 |
zinc finger CCCH-type containing 13 |
10622 |
0.19 |
chr5_178636819_178636970 | 0.90 |
ADAMTS2 |
ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
135537 |
0.04 |
chr19_16175455_16175640 | 0.90 |
TPM4 |
tropomyosin 4 |
2284 |
0.28 |
chr6_160457258_160457573 | 0.89 |
AIRN |
antisense of IGF2R non-protein coding RNA |
28719 |
0.19 |
chr2_47075547_47075844 | 0.89 |
AC016722.3 |
|
4940 |
0.18 |
chr11_19617834_19617985 | 0.89 |
ENSG00000207407 |
. |
5071 |
0.23 |
chr8_26468684_26468943 | 0.89 |
DPYSL2 |
dihydropyrimidinase-like 2 |
32892 |
0.22 |
chr6_3517760_3517987 | 0.89 |
SLC22A23 |
solute carrier family 22, member 23 |
60617 |
0.14 |
chr19_3374038_3374830 | 0.89 |
NFIC |
nuclear factor I/C (CCAAT-binding transcription factor) |
7850 |
0.19 |
chr1_26069915_26070195 | 0.89 |
MAN1C1 |
mannosidase, alpha, class 1C, member 1 |
33962 |
0.11 |
chr10_84741149_84741300 | 0.89 |
ENSG00000200774 |
. |
86603 |
0.11 |
chr8_62441280_62441551 | 0.89 |
ENSG00000222898 |
. |
103156 |
0.07 |
chr4_111788854_111789005 | 0.89 |
ENSG00000215961 |
. |
7126 |
0.26 |
chr1_211813046_211813327 | 0.88 |
ENSG00000222080 |
. |
13705 |
0.17 |
chr3_45589006_45589723 | 0.88 |
LARS2-AS1 |
LARS2 antisense RNA 1 |
38327 |
0.14 |
chr17_61476021_61476373 | 0.88 |
TANC2 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
3093 |
0.19 |
chr9_136821061_136821623 | 0.87 |
VAV2 |
vav 2 guanine nucleotide exchange factor |
36061 |
0.16 |
chr17_56031434_56032135 | 0.87 |
CUEDC1 |
CUE domain containing 1 |
834 |
0.58 |
chr9_137221477_137221979 | 0.87 |
RXRA |
retinoid X receptor, alpha |
3302 |
0.32 |
chr2_73168124_73168275 | 0.87 |
EMX1 |
empty spiracles homeobox 1 |
17082 |
0.22 |
chr1_82170023_82170174 | 0.87 |
LPHN2 |
latrophilin 2 |
4643 |
0.33 |
chr17_76296960_76297664 | 0.87 |
SOCS3 |
suppressor of cytokine signaling 3 |
58843 |
0.08 |
chr10_71232490_71232954 | 0.87 |
TSPAN15 |
tetraspanin 15 |
10902 |
0.21 |
chr11_130253262_130253480 | 0.87 |
ADAMTS8 |
ADAM metallopeptidase with thrombospondin type 1 motif, 8 |
45517 |
0.15 |
chr2_223656927_223657285 | 0.87 |
ACSL3 |
acyl-CoA synthetase long-chain family member 3 |
68546 |
0.11 |
chr2_20783837_20783988 | 0.87 |
HS1BP3-IT1 |
HS1BP3 intronic transcript 1 (non-protein coding) |
8396 |
0.23 |
chr2_45405539_45405768 | 0.87 |
SIX2 |
SIX homeobox 2 |
169084 |
0.04 |
chr17_59338529_59338680 | 0.86 |
RP11-332H18.3 |
|
121542 |
0.04 |
chr11_47436115_47436266 | 0.86 |
SLC39A13 |
solute carrier family 39 (zinc transporter), member 13 |
4554 |
0.1 |
chr6_72117351_72117502 | 0.86 |
ENSG00000207827 |
. |
4102 |
0.26 |
chr2_12309399_12309710 | 0.86 |
ENSG00000264089 |
. |
29702 |
0.24 |
chr5_149891046_149891255 | 0.86 |
NDST1 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
3476 |
0.23 |
chr10_52760926_52761077 | 0.86 |
PRKG1 |
protein kinase, cGMP-dependent, type I |
9883 |
0.26 |
chr3_134051085_134051236 | 0.86 |
AMOTL2 |
angiomotin like 2 |
39594 |
0.16 |
chr19_18773709_18774267 | 0.86 |
CRTC1 |
CREB regulated transcription coactivator 1 |
20499 |
0.1 |
chr13_80622698_80622900 | 0.86 |
SPRY2 |
sprouty homolog 2 (Drosophila) |
290995 |
0.01 |
chr1_201717737_201718015 | 0.86 |
NAV1 |
neuron navigator 1 |
8880 |
0.13 |
chr15_31898343_31898494 | 0.86 |
OTUD7A |
OTU domain containing 7A |
49124 |
0.19 |
chr5_138288736_138289663 | 0.86 |
CTNNA1 |
catenin (cadherin-associated protein), alpha 1, 102kDa |
22872 |
0.17 |
chr8_129875437_129875588 | 0.85 |
ENSG00000221351 |
. |
43472 |
0.21 |
chr7_130928825_130928976 | 0.85 |
MKLN1 |
muskelin 1, intracellular mediator containing kelch motifs |
40921 |
0.19 |
chr17_5689498_5689649 | 0.85 |
WSCD1 |
WSC domain containing 1 |
13327 |
0.28 |
chr7_73314750_73314901 | 0.85 |
WBSCR28 |
Williams-Beuren syndrome chromosome region 28 |
39336 |
0.13 |
chr17_75361709_75362043 | 0.85 |
SEPT9 |
septin 9 |
7396 |
0.18 |
chr2_17797448_17797743 | 0.85 |
VSNL1 |
visinin-like 1 |
75168 |
0.11 |
chr14_75085505_75086322 | 0.85 |
LTBP2 |
latent transforming growth factor beta binding protein 2 |
6607 |
0.2 |
chr5_34496951_34497135 | 0.85 |
RAI14 |
retinoic acid induced 14 |
159299 |
0.04 |
chr1_9352292_9352820 | 0.85 |
SPSB1 |
splA/ryanodine receptor domain and SOCS box containing 1 |
383 |
0.87 |
chr17_29908199_29908629 | 0.85 |
ENSG00000199187 |
. |
5984 |
0.12 |
chr3_70902825_70902976 | 0.84 |
ENSG00000221382 |
. |
25043 |
0.23 |
chr22_33834041_33834333 | 0.84 |
ENSG00000266012 |
. |
1532 |
0.51 |
chr14_55584461_55585066 | 0.84 |
LGALS3 |
lectin, galactoside-binding, soluble, 3 |
6065 |
0.24 |
chr11_128732951_128733102 | 0.84 |
KCNJ1 |
potassium inwardly-rectifying channel, subfamily J, member 1 |
4150 |
0.22 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 1.0 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.3 | 1.3 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.3 | 1.1 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) |
0.2 | 1.4 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.2 | 1.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.9 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 0.4 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.2 | 0.6 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 0.6 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 1.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.5 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.2 | 0.5 | GO:0000470 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.1 | 1.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.4 | GO:0044413 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.4 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.4 | GO:0061299 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.4 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.5 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.4 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.4 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.4 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.9 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.3 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.3 | GO:0061043 | vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.1 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.4 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.3 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.1 | 0.4 | GO:0048935 | peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.3 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.3 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.1 | 0.6 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.1 | GO:2000044 | negative regulation of heart induction by canonical Wnt signaling pathway(GO:0003136) negative regulation of cardioblast cell fate specification(GO:0009997) cardioblast cell fate commitment(GO:0042684) cardioblast cell fate specification(GO:0042685) regulation of cardioblast cell fate specification(GO:0042686) negative regulation of cardioblast differentiation(GO:0051892) cardiac cell fate specification(GO:0060912) negative regulation of heart induction(GO:1901320) negative regulation of cardiocyte differentiation(GO:1905208) regulation of cardiac cell fate specification(GO:2000043) negative regulation of cardiac cell fate specification(GO:2000044) |
0.1 | 0.2 | GO:0060433 | bronchus development(GO:0060433) |
0.1 | 0.3 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.3 | GO:0032344 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.1 | 0.3 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.3 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.6 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.3 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.3 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.1 | 0.3 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 0.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 1.9 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.1 | 0.3 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.2 | GO:0060087 | relaxation of smooth muscle(GO:0044557) relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.2 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.1 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.6 | GO:0071674 | mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.1 | 0.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.1 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.9 | GO:0060840 | artery morphogenesis(GO:0048844) artery development(GO:0060840) |
0.1 | 0.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.3 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.1 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 1.0 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.3 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.4 | GO:0007549 | dosage compensation(GO:0007549) |
0.1 | 0.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.5 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.1 | 0.2 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.2 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.2 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.1 | 0.2 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.1 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.3 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.1 | 1.1 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 0.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 1.2 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.1 | 0.2 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.1 | 0.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.2 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.2 | GO:1904376 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.2 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.3 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.2 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 0.3 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.7 | GO:0098876 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.1 | 0.1 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.3 | GO:0035307 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
0.1 | 0.9 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.2 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.1 | 0.3 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.1 | 0.4 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.2 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.1 | 0.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.2 | GO:0021681 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.3 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.1 | 0.2 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 1.6 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.1 | 0.2 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.3 | GO:1903670 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.1 | 0.2 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.0 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.0 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.0 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.5 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.3 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.3 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.2 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.1 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.0 | 0.0 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.2 | GO:0044319 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.0 | 0.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.0 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.0 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.5 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.1 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.6 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.2 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.0 | 0.3 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.0 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.3 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.1 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.2 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.2 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.0 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.2 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.0 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.3 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.0 | 0.0 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.0 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.1 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.2 | GO:0001885 | endothelial cell development(GO:0001885) |
0.0 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.0 | 0.1 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.1 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.3 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.0 | 0.4 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0009158 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.4 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.0 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.4 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.0 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
0.0 | 0.0 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.0 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.1 | GO:0030540 | female genitalia development(GO:0030540) |
0.0 | 0.0 | GO:1902624 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.1 | GO:0044321 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.3 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.0 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.0 | 0.1 | GO:0034393 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.5 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.1 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.1 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.4 | GO:0034767 | positive regulation of transmembrane transport(GO:0034764) positive regulation of ion transmembrane transport(GO:0034767) |
0.0 | 0.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.1 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.0 | 0.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) |
0.0 | 0.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.1 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.2 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.2 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.0 | 0.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 0.0 | GO:2000189 | regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.2 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.0 | 0.0 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.0 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.0 | 0.2 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.1 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.0 | 0.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.0 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.2 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0034653 | isoprenoid catabolic process(GO:0008300) diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.0 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.2 | GO:0090114 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.0 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.0 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.0 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.0 | 0.0 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.0 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.0 | GO:0015872 | dopamine transport(GO:0015872) |
0.0 | 0.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 0.3 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0007619 | courtship behavior(GO:0007619) |
0.0 | 0.0 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.0 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.9 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 0.0 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.9 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.1 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.1 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.0 | 0.1 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.0 | GO:0060435 | bronchiole development(GO:0060435) |
0.0 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.1 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.0 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.1 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.1 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) |
0.0 | 0.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.0 | GO:0060083 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 0.0 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.0 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.0 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.0 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of T cell apoptotic process(GO:0070234) positive regulation of leukocyte apoptotic process(GO:2000108) |
0.0 | 0.0 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 0.1 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.1 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.4 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.0 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.0 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.1 | GO:0032527 | retrograde protein transport, ER to cytosol(GO:0030970) protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.1 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.0 | GO:0044058 | regulation of digestive system process(GO:0044058) |
0.0 | 0.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.0 | GO:0045007 | depurination(GO:0045007) |
0.0 | 0.1 | GO:0050812 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.0 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.0 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.0 | 0.0 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.0 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.1 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.0 | GO:0052312 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.0 | 0.1 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.0 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.0 | 0.5 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.0 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.2 | GO:0007595 | lactation(GO:0007595) |
0.0 | 0.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.0 | GO:0098810 | neurotransmitter reuptake(GO:0098810) |
0.0 | 0.0 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.0 | GO:0070472 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.0 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 0.0 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.0 | 0.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.0 | GO:0003079 | obsolete positive regulation of natriuresis(GO:0003079) |
0.0 | 0.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.0 | 0.0 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.0 | 0.0 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.0 | 0.0 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.0 | 0.0 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.0 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.0 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.0 | 0.0 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.1 | GO:0008595 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.8 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 0.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 1.1 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 0.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.3 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 0.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.3 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 7.9 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.2 | GO:0033646 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.5 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 0.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.2 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.4 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.2 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.7 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.3 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.1 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.0 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.2 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 1.8 | GO:0060205 | cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
0.0 | 0.5 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 2.5 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.1 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.0 | 0.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.5 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.1 | GO:0043256 | laminin complex(GO:0043256) |
0.0 | 0.0 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.8 | GO:0031674 | I band(GO:0031674) |
0.0 | 0.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 1.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.4 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.0 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.0 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.3 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.3 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.2 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 3.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 0.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 1.2 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 0.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 0.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.7 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 0.7 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.2 | 0.9 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.2 | 0.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 0.7 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.2 | 0.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 1.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 1.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 1.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.8 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 0.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 1.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.4 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.6 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.8 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.8 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.3 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 0.3 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 0.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.4 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.7 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.1 | 0.2 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.3 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.2 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.2 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.2 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.2 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.3 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 1.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.5 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.2 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.1 | 0.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.8 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.0 | 0.2 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.1 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.4 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 1.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.2 | GO:0016531 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.0 | 0.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.2 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.2 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.4 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.2 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.3 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.4 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0001077 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.2 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.0 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.0 | 0.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.6 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 1.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.0 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.3 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.2 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.1 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 1.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:0004340 | glucokinase activity(GO:0004340) |
0.0 | 0.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.0 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.0 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.2 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.2 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.1 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.0 | 0.4 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.0 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.5 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.0 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.0 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.7 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.0 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.0 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 2.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 3.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 2.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 1.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 1.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 1.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 1.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 1.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 3.0 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.5 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.1 | REACTOME NFKB AND MAP KINASES ACTIVATION MEDIATED BY TLR4 SIGNALING REPERTOIRE | Genes involved in NFkB and MAP kinases activation mediated by TLR4 signaling repertoire |
0.1 | 0.8 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.7 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.1 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 2.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 2.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.1 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.0 | 0.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.2 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
0.0 | 0.0 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 0.0 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |